The price of agilon health inc. (NYSE:AGL) shares last traded on Wall Street fell -2.56% to $16.72.
Based on available information, 15 analysts follow agilon health inc. (NYSE:AGL). The consensus rating among analysts is ‘Buy’. As we calculate the median target price by taking the range between a high of $41.00 and a low of $21.00, we find $28.00. Given the previous closing price of $17.16, this indicates a potential upside of 63.17 percent. AGL stock price is now -6.93% away from the 50-day moving average and -18.88% away from the 200-day moving average. The market capitalization of the company currently stands at $6.79B.
Among analysts, 2 rate the stock a hold while 13 rate it a buy. Brokers who have rated the stock have averaged $28.92 as their price target over the next twelve months.
With the price target of $22.50, Evercore ISI recently initiated with In-line rating for agilon health inc. (NYSE: AGL).
In other news, Shaker Benjamin, Chief Markets Officer sold 18,750 shares of the company’s stock on Aug 15. The stock was sold for $339,309 at an average price of $18.10. Upon completion of the transaction, the Chief Markets Officer now directly owns 79,543 shares in the company, valued at $1.33 million. An SEC document containing details of the transaction can be found on the SEC’s website. On Aug 14, Chief Markets Officer Shaker Benjamin sold 18,750 shares of the business’s stock. A total of $351,082 was realized by selling the stock at an average price of $18.72. This leaves the insider owning 79,543 shares of the company worth $1.33 million. Insiders disposed of 95,748,861 shares of company stock worth roughly $1.6 billion over the past 1 year. A total of 0.10% of the company’s stock is owned by insiders.
There have been several recent changes in the stakes of large investors in AGL stock. A new stake in agilon health inc. shares was purchased by GHISALLO CAPITAL MANAGEMENT LLC during the first quarter worth $16,720,000. TWINBEECH CAPITAL LP invested $12,905,000 in shares of AGL during the first quarter. In the first quarter, ALYESKA INVESTMENT GROUP, L.P. acquired a new stake in agilon health inc. valued at approximately $7,076,000. NATIXIS acquired a new stake in AGL for approximately $3,902,000. MAVEN SECURITIES LTD purchased a new stake in AGL valued at around $3,344,000 in the second quarter. In total, there are 281 active investors with 108.48% ownership of the company’s stock.
A candlestick chart of agilon health inc. (NYSE: AGL) showed a price of $17.08 on Thursday morning. During the past 12 months, agilon health inc. has had a low of $15.00 and a high of $29.44. As of last week, the company has a debt-to-equity ratio of 0.05, a current ratio of 1.50, and a quick ratio of 1.50. The fifty day moving average price for AGL is $17.88 and a two-hundred day moving average price translates $20.61 for the stock.
The latest earnings results from agilon health inc. (NYSE: AGL) was released for Jun, 2023. According to the Medical Care Facilities Company, earnings per share came in at -$0.04, missing analysts’ expectations of -$0.02 by -0.02. This compares to -$0.05 EPS in the same period last year. The net profit margin was -2.40% and return on equity was -8.60% for AGL. The company reported revenue of $1.15 billion for the quarter, compared to $670.13 million a year earlier. Comparatively to last year’s same quarter, the company’s quarterly revenue rose 71.47 percent. For the current quarter, analysts expect AGL to generate $1.14B in revenue.
agilon health inc.(AGL) Company Profile
agilon health, inc. offers healthcare services for seniors through primary care physicians in the communities of the United States. As of December 31, 2022, it served approximately 269,500 medicare advantage members and 89,000 Medicare fee-for-service beneficiaries. The company was formerly known as Agilon Health Topco, Inc. and changed its name to agilon health, inc. in March 2021. agilon health, inc. was founded in 2016 and is based in Austin, Texas.
